Ozone therapy, a supplement for patients with fibromyalgia

Brenda P. Longas Vélez


Fibromyalgia is a disease of unknown cause whose main symptom is chronic widespread musculoskeletal pain accompanied by symptoms that disrupt daily activities of patients. In this study the impact of ozone therapy in improving patients' pain and daily activities to give them a better quality of life was assessed. Clinical experience is described using ozone therapy in 30 women aged 30-65 years diagnosed with Fibromyalgia, Visual Analogue Scale (VAS) 6-9, with a time of disease progression between 1-10 years. Patients were treated with O2-O3 intramuscular with 10 sessions 2 times a week at doses of 15 mg / mL, together were administered systemically 10 sessions 2 times a week alternating rectal insufflation and intravenous administration of saline 0.9% ozonated. The outcome of patients was continued by monitoring clinical symptoms and evaluation of the Visual Analogue Scale. The results showed an improvement in pain with 33% VAS 3-4 in the second week, improved sleep disorder in 46.6%, mood and daily activities by 40% and appreciated a decrease in the amount of drugs consumed by 30% of patients. The ozone therapy can be considered as an interesting as adjuvant therapy in the symptoms of fibromyalgia.

Texto completo: PDF


  • No hay Refbacks actualmente.